Cancer Communications
indexed by SCI
BMC

About the cover
About the cover

Nov. 2016; Volume 35 Issue 11

In November 2005, the first oncolytic virus, a genetically modified adenovirus, named H101 by Shanghai Sunway Biotech, gained regulatory approval from China's State Food and Drug Administration (SFDA) for the treatment of head and neck cancer.


Research Highlight
Treatment implications of posterior fossa ependymoma subgroups
Vijay Ramaswamy and Michael D. Taylor
[ Abstract  636]  [ PDF Full-text  834]   [ HTML Full-text  509]    Epub: 2016-11-22  doi: DOI: 10.1186/s40880-016-0155-6
Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Wen-Fei Li, Lei Chen, Ying Sun and Jun Ma
[ Abstract  542]  [ PDF Full-text  810]   [ HTML Full-text  523]    Epub: 2016-11-21  doi: 10.1186/s40880-016-0157-4
A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
Xiufeng Pang and Mingyao Liu
[ Abstract  697]  [ PDF Full-text  961]   [ HTML Full-text  528]    Epub: 2016-10-28  doi: 10.1186/s40880-016-0154-7
Review
What do oncologists need to know about biosimilar products?
Linda K. S. Leung, Kevin Mok, Calvin Liu and Stephen L. Chan
[ Abstract  1192]  [ PDF Full-text  944]   [ HTML Full-text  382]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0151-x
Original Article
Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study
Qian Zhao, Wen-Long Yu, Xin-Yuan Lu, Hui Dong, Yi-Jin Gu, Xia Sheng, Wen-Ming Cong and Meng-Chao Wu
[ Abstract  1159]  [ PDF Full-text  1212]   [ HTML Full-text  400]    Epub: 2016-8-24  doi: 10.1186/s40880-016-0146-7
Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case–control study
Limin Miao, Lihua Wang, Longbiao Zhu, Jiangbo Du, Xun Zhu, Yuming Niu, Ruixia Wang, Zhibin Hu, Ning Chen, Hongbing Shen and Hongxia Ma
[ Abstract  781]  [ PDF Full-text  981]   [ HTML Full-text  626]    Epub: 2016-8-11  doi: 10.1186/s40880-016-0136-9
Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients
Chen-Yue Qian, Yi Zheng, Ying Wang, Juan Chen, Jun-Yan Liu, Hong-Hao Zhou, Ji-Ye Yin and Zhao-Qian Liu
[ Abstract  805]  [ PDF Full-text  1069]   [ HTML Full-text  593]    Epub: 2016-9-2  doi: 10.1186/s40880-016-0145-8
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients
Ya-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, Wen-Juan Ma, Yong Li, Yan-Fang Ye, Hu Liang, Liang-Ru Ke, Xing Lv, Jing Yang, Yan-Qun Xiang and Xiang Guo
[ Abstract  1233]  [ PDF Full-text  1119]   [ HTML Full-text  489]    Epub: 2016-6-29  doi: 10.1186/s40880-016-0124-0
Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
Lie-Qiang Liao, Hong-Hong Yan, Jun-Hao Mai, Wei-Wei Liu, Hao Li, Zhu-Ming Guo, Zong-Yuan Zeng and Xue-Kui Liu
[ Abstract  699]  [ PDF Full-text  725]   [ HTML Full-text  563]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0153-8
Case Report
Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period
Fumio Asano, Keisuke Watanabe, Masaharu Shinkai, Yoshitaka Tei, Kei Mishina, Mikiko Tanabe, Hiroshi Ishii, Masahiro Shinoda, Tadasuke Shimokawaji, Makoto Kudo and Takeshi Kaneko
[ Abstract  942]  [ PDF Full-text  1224]   [ HTML Full-text  845]    Epub: 2016-7-2  doi: 10.1186/s40880-016-0127-x




CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China